Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4416911 | 5735725 | I | 4416911-7 | 20040721 | 20040802 | EXP | SUS1-2004-00424 | SHIRE PHARMACEUTICAL DEVELOPMENT INC. | 22 | YR | M | N | 20040729 | MD |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4416911 | 1005082538 | PS | ADDERALL 10 | 1 | 45 MG, 3X/DAY:TID | Y | D | 11522 | |||
| 4416911 | 1005108181 | C | ESCITALOPRAM (ESCITALOPRAM) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4416911 | 1005082538 | ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4416911 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4416911 | ABNORMAL BEHAVIOUR |
| 4416911 | AGITATION |
| 4416911 | ASPARTATE AMINOTRANSFERASE INCREASED |
| 4416911 | BLOOD BILIRUBIN INCREASED |
| 4416911 | BLOOD CREATINE PHOSPHOKINASE INCREASED |
| 4416911 | CHOREA |
| 4416911 | DRUG SCREEN POSITIVE |
| 4416911 | LOGORRHOEA |
| 4416911 | NAUSEA |
| 4416911 | TREMOR |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4416911 | HP |
| 4416911 | LIT |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4416911 | 1005082538 | 5 | DAY |